Clinical Microbiology in India: Diagnostic Innovations, Implementation Barriers and Future Research Priorities
Jignyasa Pattanaik*, Krishna Kumar, J. K. Pattanaik, Sanskriti Tripathy, Tridibesh Tripathy
Abstract
Clinical microbiology plays a vital role in the diagnosis and management of infectious diseases, antimicrobial susceptibility testing, and antimicrobial resistance (AMR) surveillance. In India, diagnostic practices have evolved from conventional culture-based methods towards automated systems, molecular diagnostics, rapid point-of-care testing, and sequencing-based technologies. However, the implementation of these innovations remains challenged by disparities in healthcare infrastructure, affordability, workforce capacity, and laboratory quality assurance. This scoping review aims to examine the evolution of clinical microbiology in India, evaluate the contributions of conventional and advanced diagnostic technologies, identify barriers to their implementation, and highlight research priorities for strengthening diagnostic services. A scoping review approach was adopted to explore literature published between 2005 and 2026 concerning diagnostic innovations, clinical microbiology practices, antimicrobial resistance surveillance, and implementation challenges, with particular emphasis on India and relevant evidence from comparable healthcare settings. The literature was examined thematically to identify technological developments, comparative diagnostic considerations, health-system barriers, and gaps in clinical and economic evidence. The reviewed literature indicates a transition towards integrated diagnostic approaches combining conventional microbiology with molecular and advanced diagnostic technologies. Molecular assays offer opportunities for rapid pathogen identification and detection of selected resistance determinants, while sequencing-based methods support broader pathogen characterization and epidemiological surveillance. Nevertheless, conventional culture and phenotypic antimicrobial susceptibility testing remain essential for organism recovery and comprehensive susceptibility assessment. Major implementation barriers include unequal access to diagnostic facilities, inadequate infrastructure, limited trained personnel, quality-control challenges, affordability, and difficulties in translating diagnostic innovations into routine clinical practice. The evidence also highlights the need for stronger evaluations of clinical utility, antimicrobial prescribing outcomes, cost-effectiveness, and sustainable implementation. The evolution of clinical microbiology in India involves not only technological advancement but also the challenge of ensuring equitable, reliable, and sustainable diagnostic services. Integrating conventional and advanced diagnostic methods, strengthening laboratory capacity, and generating context-specific clinical and economic evidence are essential to improve diagnostic decision-making and antimicrobial resistance surveillance. Future research should prioritize implementation feasibility, affordability, patient outcomes, and access to advanced diagnostics across diverse healthcare settings.